Zimmer Biomet Holdings Company Profile (NYSE:ZBH)

About Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NYSE:ZBH
  • CUSIP: N/A
  • Web: www.zimmer.com
Capitalization:
  • Market Cap: $24.06 billion
  • Outstanding Shares: 201,644,000
Average Prices:
  • 50 Day Moving Avg: $119.84
  • 200 Day Moving Avg: $113.60
  • 52 Week Range: $95.63 - $133.21
P/E:
  • Trailing P/E Ratio: 48.75
  • Foreward P/E Ratio: 12.86
  • P/E Growth: 1.42
Sales & Book Value:
  • Annual Revenue: $7.76 billion
  • Price / Sales: 3.10
  • Book Value: $49.27 per share
  • Price / Book: 2.42
Dividend:
  • Annual Dividend: $0.96
  • Dividend Yield: 0.8%
Profitability:
  • EBIDTA: $2.81 billion
  • Net Margins: 3.90%
  • Return on Equity: 16.66%
  • Return on Assets: 6.07%
Debt:
  • Debt-to-Equity Ratio: 1.11%
  • Current Ratio: 1.95%
  • Quick Ratio: 1.13%
Misc:
  • Average Volume: 1.28 million shs.
  • Beta: 1.2
  • Short Ratio: 3.66
 

Frequently Asked Questions for Zimmer Biomet Holdings (NYSE:ZBH)

What is Zimmer Biomet Holdings' stock symbol?

Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet Holdings pay dividends? What is the dividend yield for Zimmer Biomet Holdings?

Zimmer Biomet Holdings announced a quarterly dividend on Wednesday, March 1st. Shareholders of record on Friday, March 31st will be paid a dividend of $0.24 per share on Friday, April 28th. This represents a $0.96 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend is Wednesday, March 29th. View Zimmer Biomet Holdings' Dividend History.

How were Zimmer Biomet Holdings' earnings last quarter?

Zimmer Biomet Holdings Inc (NYSE:ZBH) posted its quarterly earnings results on Thursday, April, 27th. The company reported $2.13 earnings per share for the quarter, beating the consensus estimate of $2.11 by $0.02. The firm earned $1.98 billion during the quarter, compared to analyst estimates of $1.96 billion. Zimmer Biomet Holdings had a net margin of 3.90% and a return on equity of 16.66%. The business's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the business posted $2.00 EPS. View Zimmer Biomet Holdings' Earnings History.

When will Zimmer Biomet Holdings make its next earnings announcement?

Zimmer Biomet Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, July, 26th 2017. View Earnings Estimates for Zimmer Biomet Holdings.

Where is Zimmer Biomet Holdings' stock going? Where will Zimmer Biomet Holdings' stock price be in 2017?

20 brokers have issued 12 month target prices for Zimmer Biomet Holdings' stock. Their predictions range from $92.00 to $155.00. On average, they anticipate Zimmer Biomet Holdings' stock price to reach $133.75 in the next twelve months. View Analyst Ratings for Zimmer Biomet Holdings.

What are analysts saying about Zimmer Biomet Holdings stock?

Here are some recent quotes from research analysts about Zimmer Biomet Holdings stock:

  • 1. Canaccord Genuity analysts commented, "SGEN reported 1Q earnings and provided a pipeline update." (4/28/2017)
  • 2. According to Zacks Investment Research, "Ahead of its first quarter earnings, Zimmer Biomet is trading above Zacks categorized Medical Product industry in the last one month. The company’s last reported fourth quarter 2016 results were impressive. However Zimmer Bioment continues to experience dismal performance in its dental segment. Factors like macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations are the major headwinds. On a positive note, the company is witnessing improvement in its knees segment. We are looking forward to the synergy from the LDR Holding acquisition, which should complement its musculoskeletal offering. Management's 2017 guidance is also encouraging as it indicates sustainability of Zimmer Biomet’s growth." (4/13/2017)
  • 3. Needham & Company LLC analysts commented, "We hosted a dinner and investor meetings with Dan Florin, Senior Vice President and CFO, and Bob Marshall, Treasurer and Vice President of Investor Relations this week in New York City. We think that the discussion was upbeat and highlighted ZBH's progress in addressing its manufacturing challenges, its non-recon business performance, margin opportunities, and cash flow outlook. The meetings reinforced our view that ZBH should be able to drive its revenue growth to sustainable mid-single digit growth with a combination of market growth in recon and above-market growth in its non-recon businesses. We reiterate our Strong Buy rating." (2/17/2017)
  • 4. JPMorgan Chase & Co. analysts commented, "Zimmer’s re-acceleration continued into 2Q earnings as sales grew 4.5% pro- forma and 2.6% organic excluding an extra selling day. Organic growth came in well above the Street’s call for 1.6% organic growth and buy-side calls for 1.9% (see our recent survey here). The sales beat was broad based with each business performing in-line or better than Street estimates with Knees (+$2M), Hips (+$9M), SET (+$20M), and Dental (+$5M) as the standout performers in the quarter. While gross margins were lower than expected (70bps), this was tempered by in-line operating expense and a better than expected tax rate including benefits from the early adoption of ASU 2016-09 (+$0.01). When factoring in the better than expected top-line, this drove a $0.05 Cash EPS beat. With Zimmer’s turnaround tracking ahead of expectations, we reiterate our Overweight rating on the stock and raise our price target from $134 to $148 (Y/E 17), conservatively valuing the stock at 15x 2018 Cash EPS, a 20% discount to its peers." (7/29/2016)

Who are some of Zimmer Biomet Holdings' key competitors?

Who owns Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (9.31%), BlackRock Inc. (8.32%), Vanguard Group Inc. (6.49%), State Street Corp (4.07%), Longview Partners Guernsey LTD (3.04%) and FMR LLC (2.65%). Company insiders that own Zimmer Biomet Holdings stock include Adam Rudolph Johnson, Blackstone Capital Partners V, Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Stuart G Kleopfer and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet Holdings.

Who sold Zimmer Biomet Holdings stock? Who is selling Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Ameriprise Financial Inc., Marshall Wace LLP, Massachusetts Financial Services Co. MA, Janus Capital Management LLC, Russell Investments Group Ltd., OppenheimerFunds Inc. and Longview Partners Guernsey LTD. Company insiders that have sold Zimmer Biomet Holdings stock in the last year include Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Stuart G Kleopfer and Tony W Collins. View Insider Buying and Selling for Zimmer Biomet Holdings.

Who bought Zimmer Biomet Holdings stock? Who is buying Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Nordea Investment Management AB, Glenview Capital Management LLC, Point72 Asset Management L.P., Vanguard Group Inc., Neuberger Berman Group LLC, California Public Employees Retirement System and MARSHALL WACE ASIA Ltd. View Insider Buying and Selling for Zimmer Biomet Holdings.

How do I buy Zimmer Biomet Holdings stock?

Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Zimmer Biomet Holdings stock cost?

One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $119.30.

Analyst Ratings

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZBH) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 14 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $133.75 (12.11% upside)

Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZBH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/16/2017Goldman Sachs Group IncInitiated CoverageSell -> Sell$92.00HighView Rating Details
4/28/2017Canaccord GenuityReiterated RatingBuyLowView Rating Details
4/28/2017Oppenheimer Holdings Inc.Set Price TargetBuy$132.00LowView Rating Details
4/28/2017Needham & Company LLCBoost Price TargetStrong-Buy -> Strong-Buy$151.00 -> $153.00MediumView Rating Details
4/28/2017Wells Fargo & CoDowngradeOutperform -> Market PerformMediumView Rating Details
3/14/2017Royal Bank of CanadaReiterated RatingBuy$133.00MediumView Rating Details
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 -> $136.00N/AView Rating Details
1/5/2017JPMorgan Chase & Co.Set Price TargetBuy$134.00N/AView Rating Details
11/29/2016Citigroup IncUpgradeSell -> NeutralN/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
11/1/2016Leerink SwannReiterated RatingOutperform$150.00 -> $136.00N/AView Rating Details
11/1/2016Jefferies Group LLCLower Price TargetBuy$150.00 -> $129.00N/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016Barclays PLCBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
8/11/2016SunTrust Banks, Inc.Initiated CoverageBuy$155.00N/AView Rating Details
7/29/2016BMO Capital MarketsReiterated RatingBuy$146.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$125.00N/AView Rating Details
6/8/2016Morgan StanleyReiterated RatingBuyN/AView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
3/20/2016Bank of America CorpInitiated CoverageBuy$127.00N/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00N/AView Rating Details
1/31/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00N/AView Rating Details
10/30/2015Brean CapitalReiterated RatingHoldN/AView Rating Details
10/9/2015Credit Suisse Group AGInitiated CoverageOutperform$107.00N/AView Rating Details
7/29/2015Deutsche Bank AGReiterated RatingHold$114.00N/AView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Zimmer Biomet Holdings (NYSE:ZBH)
Earnings by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Earnings History by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2017        
4/27/2017Q1 2017$2.11$2.13$1.96 billion$1.98 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZBH)
2017 EPS Consensus Estimate: $8.54
2018 EPS Consensus Estimate: $9.35
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$2.10$2.14$2.11
Q2 20176$2.08$2.18$2.12
Q3 20176$1.91$2.01$1.96
Q4 20176$2.32$2.41$2.36
Q1 20183$2.25$2.32$2.29
Q2 20183$2.27$2.39$2.33
Q3 20182$2.15$2.16$2.16
Q4 20182$2.56$2.61$2.59
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Zimmer Biomet Holdings (NYSE:ZBH)
Most Recent Dividend:4/28/2017
Annual Dividend:$0.96
Dividend Yield:0.80%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:65.31% (Trailing 12 Months of Earnings)
11.24% (Based on This Year's Estimates)
10.34% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Dividend History by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/1/2017quarterly$0.240.81%3/29/20173/31/20174/28/2017
12/19/2016quarterly$0.240.94%12/28/201612/30/20161/27/2017
8/23/2016quarterly$0.240.74%9/21/20169/23/201610/28/2016
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Ownership Percentage: 1.22%
Institutional Ownership Percentage: 86.62%
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.36View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.87View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.43View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.00View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.73View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.00View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.00View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.00View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.70View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.00View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.00View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.00View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.56View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.00View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.00View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.00View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.20View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Zimmer Biomet Holdings (NYSE:ZBH)
Latest Headlines for Zimmer Biomet Holdings (NYSE:ZBH)
Source:
DateHeadline
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 23 at 7:22 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Now Covered by Goldman Sachs Group Inc
www.americanbankingnews.com - May 16 at 8:56 PM
finance.yahoo.com logoZimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ZBH-US : May 12, 2017
finance.yahoo.com - May 12 at 3:16 PM
finance.yahoo.com logoJeff Auxier Comments on Zimmer Biomet Holdings
finance.yahoo.com - May 10 at 9:03 AM
finance.yahoo.com logoZimmer Biomet Named Top Workplace on Forbes' "America's Best Large Employers of 2017" List
finance.yahoo.com - May 9 at 8:46 PM
americanbankingnews.com logoInsider Selling: Zimmer Biomet Holdings Inc (ZBH) VP Sells 6,200 Shares of Stock
www.americanbankingnews.com - May 9 at 10:30 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Receives $139.36 Average Target Price from Brokerages
www.americanbankingnews.com - May 4 at 1:27 AM
americanbankingnews.com logoZimmer Biomet Holdings (ZBH) Earning Somewhat Positive News Coverage, Report Shows
www.americanbankingnews.com - May 3 at 4:24 PM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Forecasted to Post Q3 2017 Earnings of $1.91 Per Share
www.americanbankingnews.com - May 3 at 10:06 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc Forecasted to Earn Q2 2017 Earnings of $2.13 Per Share (ZBH)
www.americanbankingnews.com - May 2 at 8:08 AM
americanbankingnews.com logoInsider Selling: Zimmer Biomet Holdings Inc (ZBH) Insider Sells 87,331 Shares of Stock
www.americanbankingnews.com - May 1 at 9:38 PM
finance.yahoo.com logoZimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : May 1, 2017
finance.yahoo.com - May 1 at 7:51 PM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) to Post FY2019 Earnings of $10.29 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - May 1 at 2:36 PM
americanbankingnews.com logoAnalysts Set Expectations for Zimmer Biomet Holdings Inc's FY2017 Earnings (ZBH)
www.americanbankingnews.com - May 1 at 9:16 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc to Post Q2 2017 Earnings of $2.11 Per Share, Oppenheimer Holdings Forecasts (ZBH)
www.americanbankingnews.com - May 1 at 7:09 AM
americanbankingnews.com logoQ2 2017 Earnings Estimate for Zimmer Biomet Holdings Inc (ZBH) Issued By SunTrust Banks
www.americanbankingnews.com - May 1 at 7:09 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Expected to Post Quarterly Sales of $1.99 Billion
www.americanbankingnews.com - April 30 at 10:14 AM
americanbankingnews.com logoZimmer Biomet Holdings (ZBH) Given Daily Coverage Optimism Rating of 0.17
www.americanbankingnews.com - April 30 at 8:24 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Downgraded by Wells Fargo & Co to Market Perform
www.americanbankingnews.com - April 29 at 6:53 PM
americanbankingnews.com logoNeedham & Company LLC Raises Zimmer Biomet Holdings Inc (ZBH) Price Target to $153.00
www.americanbankingnews.com - April 29 at 5:36 PM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) PT Set at $132.00 by Oppenheimer Holdings Inc.
www.americanbankingnews.com - April 29 at 12:11 PM
finance.yahoo.com logoZimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : April 28, 2017
finance.yahoo.com - April 29 at 2:53 AM
finance.yahoo.com logoEdited Transcript of ZBH earnings conference call or presentation 27-Apr-17 12:00pm GMT
finance.yahoo.com - April 29 at 2:53 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - April 29 at 1:00 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Expected to Announce Earnings of $2.16 Per Share
www.americanbankingnews.com - April 28 at 11:10 AM
americanbankingnews.com logoWilliam Blair Comments on Zimmer Biomet Holdings Inc's Q2 2017 Earnings (ZBH)
www.americanbankingnews.com - April 28 at 8:22 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 28 at 8:13 AM
seekingalpha.com logoZimmer Biomet Holdings' (ZBH) CEO David Dvorak on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - April 28 at 2:57 AM
investorplace.com logoWhy Vale SA (ADR) (VALE), Zimmer Biomet Holdings Inc (ZBH) and American Airlines Group Inc (AAL) Are 3 of Today’s Worst Stocks
investorplace.com - April 27 at 5:12 PM
investorplace.com logoWhy Vale SA (ADR) (VALE), Zimmer Biomet Holdings Inc (ZBH) and American Airlines Group Inc (AAL) Are 3 of Today’s Worst Stocks
investorplace.com - April 27 at 4:57 PM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) Posts Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - April 27 at 4:50 PM
seekingalpha.com logoZimmer Biomet Q1 top line up 4%; earnings up 175%; cash flow up 1%; EPS guidance raised; shares down 4% premarket on soft revenue guidance
seekingalpha.com - April 27 at 11:24 AM
nasdaq.com logoZimmer Biomet Holdings Inc. Reveals 6% Rise In Q1 Profit
www.nasdaq.com - April 27 at 11:24 AM
finance.yahoo.com logoZimmer Biomet Reports First Quarter 2017 Financial Results
finance.yahoo.com - April 27 at 11:24 AM
finance.yahoo.com logoZimmer Biomet (ZBH) Beats on Q1 Earnings and Sales Estimates
finance.yahoo.com - April 27 at 11:24 AM
finance.yahoo.com logoThis Medtech Stock Is Crashing Out Of Buy Range
finance.yahoo.com - April 27 at 11:24 AM
americanbankingnews.com logoZimmer Biomet Holdings (ZBH) Earns Daily Media Impact Rating of 0.07
www.americanbankingnews.com - April 27 at 8:30 AM
marketbeat.com logoZimmer beats Street 1Q forecasts
marketbeat.com - April 27 at 7:46 AM
americanbankingnews.com logoSunTrust Banks Comments on Zimmer Biomet Holdings Inc's Q1 2017 Earnings (ZBH)
www.americanbankingnews.com - April 27 at 7:27 AM
finance.yahoo.com logoHow ZBH Stock Has Performed Recently
finance.yahoo.com - April 26 at 5:26 PM
americanbankingnews.com logoSunTrust Banks Brokers Lower Earnings Estimates for Zimmer Biomet Holdings Inc (ZBH)
www.americanbankingnews.com - April 26 at 9:31 AM
zacks.com logoShould You Buy Zimmer Biomet (ZBH) Ahead of Earnings?
www.zacks.com - April 26 at 8:07 AM
finance.yahoo.com logoHow Zimmer Biomet Is Driving Growth through Acquisitions
finance.yahoo.com - April 26 at 8:07 AM
finance.yahoo.com logoWhy Zimmer Biomet Could See Revenue Growth in 1Q17
finance.yahoo.com - April 25 at 7:42 PM
americanbankingnews.com logoZimmer Biomet Holdings (ZBH) Given Daily News Impact Rating of 0.20
www.americanbankingnews.com - April 24 at 9:50 AM
americanbankingnews.com logoZimmer Biomet Holdings (ZBH) Receives News Impact Rating of 0.08
www.americanbankingnews.com - April 21 at 9:39 AM
finance.yahoo.com logoZimmer Biomet Holdings to Present at 42nd Annual Deutsche Bank Securities Annual Health Care Conference
finance.yahoo.com - April 21 at 1:30 AM
americanbankingnews.com logoZimmer Biomet Holdings Inc (ZBH) to Post Q1 2017 Earnings of $2.14 Per Share, Northcoast Research Forecasts
www.americanbankingnews.com - April 19 at 7:18 AM
finance.yahoo.com logoMedical device maker that HHS secretary invested in would benefit from new rule
finance.yahoo.com - April 18 at 7:52 PM
americanbankingnews.com logoNorthcoast Research Analysts Raise Earnings Estimates for Zimmer Biomet Holdings Inc (ZBH)
www.americanbankingnews.com - April 18 at 2:10 PM

Social

Chart

Zimmer Biomet Holdings (ZBH) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff